SSY Group Limited Projected to Win 12 Products in China’s Eleventh VBP Round
China‑based SSY Group Limited (HKG: 2005) announced today that it has been pre‑selected as the...
VBP (voluem-based procurement)
VBP 11th Finalizes 389 Participants, 3.7 Billion Doses Set for Centralized Procurement
The Office of the National Drug Joint Procurement (ONDJP) published the conclusive enterprise roster for...
National Joint Procurement Office Announces 11th Round VBP, AstraZeneca Dapagliflozin Leads Demand
On October 11, 2025, the National Joint Procurement Office (NJPO) released the full company list for...
National Drug Alliance Moves VBP 11th‑Round Information Disclosure Conference to 27 Oct 2025 in Shanghai
The National Drug Alliance Procurement Office announced a schedule change for the 11th round of...
China Drug Procurement: Centralized Rules Shape 11th Round Of VBP
The Joint Procurement Office of the National Healthcare Security Administration (NHSA) published the definitive rules...
NHSA Updates Volume-Based Procurement Policy for Medical Institutions in 11th VBP Tender
The National Healthcare Security Administration (NHSA) has released Q&As on the medical institutions’ volumes filing...
NHSA Announces Reforms to Centralized Drug Procurement Policies Beyond Lowest Price
The National Healthcare Security Administration (NHSA) held a press conference today on the “High-Quality Completion...
NHSA Strengthens Pharmaceutical Pricing and Procurement Credit Evaluation Mechanism
The National Healthcare Security Administration (NHSA) issued a notification this week to refine its credit...
CSPC Pharmaceutical Reports 7.8% Revenue Decline in 2024 Amid VBP Impact
China-based CSPC Pharmaceutical Group Ltd (HKG: 1093) reported its 2024 financial results, showing a 7.8%...
Shanghai Healthcare Administration Pushes for 11th Round of VBP
Shanghai’s Healthcare Security Administration (HSA) bureau held a work conference on April 16, 2025, to...
Shanxi Yanghe Medical Technology Faces Production Halt Over GMP Violation
China’s National Drug Alliance Procurement Office has imposed manufacturing suspensions on Shanxi Yanghe Pharmaceutical Technology’s...
Guangdong Accelerates Centralized Procurement for Apixaban and Key Therapeutics
The Guangdong Drug Trading Center has issued a critical update on preparations for the centralized...
Shanghai Designates Backup Suppliers and Specialized Drug Formulations in GY-YD2024-2 Procurement
Shanghai has finalized its list of second-tier backup suppliers and manufacturers for specialized drug formulations...
HMZS Biopharmaceutical Blacklisted After Failing to Monitor Production Process
HMZS Biopharmaceutical, a Chinese company that won a bid for its phloroglucinol in the 10th...
National Allied Procurement Office Allows VBP Winners to Adjust MAH and Manufacturing Details
The National Allied Procurement Office has issued a notification clarifying rules for China’s Volume-Based Procurement...
China’s Drug Procurement Under Scrutiny: Addressing Quality Concerns and Policy Reforms
An In – Depth Exploration of the Recent Survey on Bulk Drug Procurement in China...
NHSA Seeks Expert Opinions on VBP Drug Quality and Efficacy
The National Healthcare Security Administration (NHSA) has released a letter titled “Letter on Requesting Assistance...
10th National VBP Round Results Announced: Contracts Worth Over RMB1.3 Billion
The national Volume-Based Procurement (VBP) authorities have released comprehensive details regarding the 10th VBP round,...
National VBP Program Round 10: 195 Manufacturers Secure Winning Bids for 62 Drugs
The preliminary outcomes of the 10th round of China’s national volume-based procurement (VBP) program were...